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Abstract: Objective: This study is to investigate whether CKLF-like MARVEL transmembrane domain-containing pro-
tein 2 (CMTM2) is involved in spermatogenesis in mice. CMTM2 is highly expressed in testis, and could possibly 
a potential spermagogenesis specific gene. Methods: CMTM2-deficient mouse model was generated. Northern, 
RT-PCR and Western blotting analysis were performed on total RNA derived from wild-type (WT, CMTM2+/+) and 
CMTM2+/- (heterozygote) and CMTM2-/- (homozygote) mice to examine the CMTM2 level. The number of litters and 
the number of pups were counted and pregnancy rates calculated. The motility and morphology of the sperm and 
the histology of testes were analyzed. Serum testosterone and FSH concentrations were also measured. Standard 
t-tests (Excel, Microsoft, Redmond, WA, USA) were used and standard error of means were calculated. Results: 
CMTM2 is highly expressed in a finely regulated pattern in the mouse testis during spermatogenesis. The body 
weight of adult mice with CMTM2 deficiency was not significantly different from that of wild type mice. No obvious 
anatomical or behavioral abnormalities were observed. The testes of CMTM2-/- were smaller than that of CMTM2+/+ 
mice. Female CMTM2 null mice are fertile, indicating that CMTM2 is not required for female gametogenesis. The 
CMTM2-/- mice produced virtually no sperm, and CMTM2+/- mice sperm count showed a significant decline. The 
hormone levels are not significantly different. The CMTM2-/- male mice are sterile due to a late, complete arrest 
of spermiogenesis. The organized architecture of the seminiferous epithelium of the seminiferous tubules seen in 
CMTM2+/+ mice was lost in CMTM2-/- mice. Conclusions: This study suggests CMTM2 is not required for embryonic 
development in the mouse but is essential for spermiogenesis.
Keywords: CMTM2, sperm, gene knockout mouse model, spermiogenesis
Introduction
Reproduction and development is one of the 
most active topics in the field of biomedical 
research in recent years. Despite its impor-
tance in human health, the pathogenesis of 
male infertility remains poorly understood [1]. 
A multitude of conditions can cause male infer-
tility, such as congenital malformations, expo-
sure to polluted environment, genetic and 
endocrine disorders, and infectious, inflamma-
tory and immunologic conditions [2]. The post-
meiotic development, also known as spermio-
genesis, is dependent on the accurate expres-
sion of a large number of testis-specific genes, 
the disruption of which often results in sper-
matogenic defects and male infertility [3-5]. 
Previously, it has been reported that CMTM2 
(CKLF-like MARVEL transmembrane domain-
containing protein 2) is possibly associated 
with spermatogenesis [6]. CMTM2 is one of 
the members of CMTM family which is previ-
ously called chemokine-like factor superfamily 
(CKLFSF) (Figure 1). It is a novel protein family 
that provides a structural and functional link 
between chemokines and members of the 
transmembrane 4 super family (TM4SF) [7, 8]. 
Interestingly, most members of the CMTM fam-
ily have higher expression levels in testis, indi-
cating they might play systemic roles in sper-
matogenesis. Among members of the CMTM 
family, CMTM2 is highly expressed in testis 
(Figure 2) [9]. In addition, the importance of 
CMTM2 in spermatogenesis was suggested by 
a close correlation between CMTM2 abnormal 
expression and a spermatogenesis defect [6]. 
With the aggravation of the spermatogenesis 
defect, the CMTM2 positive cell numbers and 
mRNA level decreased significantly with no 
expression in the testes of patients with Sertoli 
Cell Only Syndrome (SCOS), which is character-
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The CMTM2 null mice were a generous gift from 
Dr. Kite Brandes at the Washington University 
in St. Louis. These mice were both on C57BL/6 
backgrounds and thus age-matched but non-
related controls from this strain were used. 
Mice were housed according to Institutional 
Animal Care and Use Committee and National 
Institutes of Health guidelines.
Dissection techniques
Adult males 8-12 weeks of age were used for 
this study. Intraperitoneal ketamine and xyla-
zine (100 mg/kg and 10 mg/kg, respectively) 
mixture was used for anesthesia. Prior to eu- 
thanasia, a midline incision was made from the 
xiphoid to pubis, and the abdominal contents 
were carefully inspected with the assistance of 
a dissecting microscope or × 2.5 loupe dissect-
ing lenses. Animals then were euthanized using 
intracardiac pentobarbital (100 mg/kg). 
Analysis of gene expression
Northern and RT-PCR analysis was perform- 
ed on total RNA derived from wild-type (WT, 
CMTM2+/+) and CMTM2+/- (heterozygote) and 
CMTM2-/- (homozygote) mice (a list of RT-PCR 
primers is available on request) using standard 
protocols. Control PCR reactions were per-
formed on CMTM2-/- RNA in the absence of 
reverse transcriptase. Immunoblots were per-
formed on testis protein extracts using the 
monoclonal antibodies (Santa Cruz Biotech- 
nology, Santa Cruz, CA, USA).
Figure 1. Genomic structure of human CMTM2. A. Schematic map of the 
human CMTM2 gene. B. Sizes of exons and introns, and splice junction se-
quences of the human CMTM2 gene.
Figure 2. Tissue distribution of human CMTM2 
mRNA. The expression of human CMTM2 was PCR-
detected in a human multiple tissue cDNA panel, 
and analyzed by agarose gel electrophoresis. The 
cDNA samples present within each MTC panel were 
pre-normalized using several housekeeping genes.
ized histologically by a com-
plete loss of the germinal epi-
thelium in human testicular 
tubules [6, 10]. This correla-
tion provided compelling evi-
dence for a crucial role of 
CMTM2 in spermatogenesis.
In this study, we have estab-
lished CMTM2 knockout mo- 
use model and observed its 
effects on male fertility from 
the aspects of reproductive 
phenotype, sperm quality, fer-
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Testes histology
Mice testes were fixed in Bouin’s fixative imme-
diately after euthanasia. Specimens were cut 
at 4 μm thickness and stained with hematoxy-
lin and eosin for examination by light microsco-
py. Specific cell counts were performed in each 
testicle in the seminiferous epithelium of five 
round-shaped seminiferous tubules, i.e. cells 
were counted in 10 tubules per mouse. Two 
independent, blind observers performed the 
cell counts.
Western blotting analysis
Western blot analysis of endogenous proteins 
from organ tissues was performed as described 
previously [6]. The following antibodies were 
used: rabbit monoclonal CMTM2 antibody (Cell 
Signaling Technology, Inc., Beverly, MA, USA), 
rabbit monoclonal glyceraldehyde-3-phospha- 
te dehydrogenase (GAPDH) antibody (Sigma-
Aldrich) and goat anti-rabbit IgG-HRP antibo- 
dy (Sigma-Aldrich). Visualization was achieved 
with the SuperSignal West Pico Chemilumin- 
escent Substrate (Thermo Fisher Scientific, 
Inc., Waltham, MA, USA).
Sperm counts, motility and morphology
Caudal epididymal sperm were collected into 
Modified Whitten’s medium. After 5 minutes, 
adequate dispersion of the sperm was deter-
mined visually, and an aliquot was diluted 1:20 
in the same medium, which was placed on a 
pre-warmed counting chamber slide (100 µm in 
depth) (Cell Vision, Hopedale, MA, USA) and 
analyzed by computer-assisted semen analysis 
(CASA) on a Hamilton-Thorne IVOS V12.2L 
analyzer (Hamilton Thorne Research, Danvers, 
MA, USA). Five randomly chosen fields were 
analyzed. Motility (%) was recorded. For total 
sperm counts, two aliquots of sperm were dilut-
ed 1:200 in water for immobilization and put 
into a hemocytometer for counting. Afterwards, 
the average of sperm concentration was calcu-
lated. For analysis of sperm morphology, ali-
quots of caudal spermatozoa were prepared as 
above in pre-warmed M16 medium and diluted 
to 105/mL. A drop of paraformaldehyde was 
added to immobilize the sperm, 3 μl-aliquots 
were transferred into 12 μl MicroCell fixed-
depth chambers (Conception Technologies, 
San Diego, CA) for visualization, and imaging 
was performed with differential interference 
contrast optics at × 40 magnification. At least 
100 sperm were counted for each genotype, 
and both head and tail morphology were 
scored. 
Fertility test
Adult male mice of three genotypes were cag- 
ed with wild type female mice of two different 
genetic backgrounds (B6 and C57BL/6). The 
reproductive capacity evaluation was per-
formed as described [11]. Male mice were 
housed with two female mice. Female mice 
were replaced weekly. When plugged female 
mice were found, they were removed and 
replaced immediately. Pregnancy was defined 
as plugged mice that gave birth to offspring. 
The number of total males and females, 
plugged females, litters, and total off-spring 
were counted to calculate frequency of copula-
tory plug (FCP), frequency of conception (FC) 
and average offspring amount (AOA). 
Measurement of hormonal levels
Blood samples were taken from mice after they 
were killed. Samples were centrifuged for 15 
minutes at 1000 × g, 4 Celsius degrees. Serum 
was removed and samples analyzed by ELISA 
kits (USCNLIFE, China) for testosterone and 
follicle-stimulating hormone (FSH). The optical 
density of the wells was determined with the 
ELISA reader SUNRISE (Tecan, Switzerland).
Statistics
Standard t-tests (Excel, Microsoft, Redmond, 
WA, USA) were used and standard error of 
means were calculated as appropriate. Stati- 
stical significance was defined as P < 0.05.  
Results
Establishment of CMTM2-deficient mouse 
model
Interbreeding of heterozygous mice produced 
36 CMTM2+/+, 38 CMTM2+/- and 20 CMTM2-/- 
mice in F2 offspring. Among 255 mice from F1 
to F8 generation, only 3 mice died, suggesting 
that CMTM2 deficiency didn’t lead to embryonic 
lethality. The CMTM2-deficient mice grew to 
adulthood with no gross abnormalities and no 
increased lethality, and the adult CMTM2 null 
mice were normal in appearance. The body 
weight of adult mice with CMTM2 deficiency 
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was not significantly different from that of wild 
type mice. No obvious anatomical or behavioral 
abnormalities were observed. Consequently, 
targeted disruption of the CMTM2 gene in mice 
was successful (Figure 3). However, we noted 
that testes of CMTM2-/- were smaller than that 
of CMTM2+/+ mice (Figure 4). The lower testis 
weight of CMTM2-/- male was not due to the 
loss of overall body weight, which was similar 
as indicated above (Table 1). 
Sperm count, motility and morphology
The sperm count and motility of CMTM2 
mutants and that of WT mice are significantly 
different. The CMTM2-/- mice produced virtually 
no sperm, and CMTM2+/- mice sperm count 
showed a significant decline (Table 1). The mor-
phology changes are also significant, as there 
were more round sperms in the CMTM2+/- mice, 
and arrest of spermatogenesis could be obs- 
erved in the CMTM2-/- mice, mostly round 
spermatids.   
Serum hormone concentration
Serum testosterone and FSH concentrations 
in CMTM2-/- males (11.90±0.52 nmol/l and 
5.33±0.12 mIU/ml, respectively), and CMTM2+/- 
(12.11±0.55 nmol/l and 5.39±0.15 mIU/ml, 
respectively) did not differentiate significantly 
from those in WT males (11.88±0.68 nmol/l 
and 5.34±0.19 mIU/ml, respectively).
Fertility outcome
Female CMTM2 null mice are fertile, indicating 
that CMTM2 is not required for female gameto-
Figure 3. Analysis of testis gene expression in CMTM2 
mutant mice. A. Northern blot analysis. The RNA 
from the mice whose genotype is shown above each 
lane was hybridized with a 32 P-labeled probe to de-
tect the expression of the gene shown below each 
panel. The CMTM2 gene expression is abolished in 
CMTM2-/- animals. B. Western blot analysis Testes of 
CMTM2+/+, CMTM2+/- and CMTM2-/- were tested for 
CMTM2 protein expression. There was a dramatic re-
duction in the expression of CMTM2 in mutant mice. 
GAPDH was used as the loading control. 
Figure 4. Comparison of the testis volume in CMTM2 
mutant mice. The testes of CMTM2-/- mice are small-
er than those of CMTM2+/+. 
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genesis. In contrast, CMTM2-/- males are infer-
tile. No significant differences were found 
among 3 groups in the ability of male mice of 
any genotype to plug wild type female mice, 
however, the CMTM2-/- mice failed to make 
female mice pregnant, and CMTM2+/- mice fer-
tility was significantly reduced as the pregnant 
females and offspring were largely fewer than 
that of CMTM2+/+ mice (Table 2). 
Testes histology
The organized architecture of the seminiferous 
epithelium of the seminiferous tubules seen in 
ferences between the number and structure of 
Leydig cells and Sertoli cells between the 3 
groups. 
Discussion
Our previous work has demonstrated that 
CMTM2 is associated with spermatogenesis in 
human [6, 9]. In the present study, we further 
investigated its role in CMTM2-deficient mouse 
models. Here, we reported that CMTM2 defi-
ciency was associated with male infertility in 
mice. 
Table 1. Reproductive physiology of CMTM2 mutant mice
Genotype Age (week) Testes weight (mg) Sperm count (107/ml) Motility (%) Morphology
CMTM2+/+ 8-12 101.63±2.33 3.28±0.34 86.33±2.98 Normal
CMTM2+/- 8-12 98.87±2.76 2.07±0.57 33.45±3.67* Many round sperms  
CMTM2-/- 8-12 85.22±2.84* 0* 0* 0*
Values are mean ± SEM. Sperm counts and motility percentage was calculated by combining sperm from both caudal epididy-
mides of mice. *P < 0.001.
Table 2. Fertility test of CMTM2 mutant mice
Male mice genotype Female mice Plugged mice Pregnant mice Offspring (M/F) AOA FCP (%) FC (%)
CMTM2+/+ (n=5) WT (n=49) 38 31 249 (132:117) 8.0 77.6 63.3
CMTM2+/- (n=5) WT (n=51) 34 13 103 (50:53) 7.9 66.7 25.5
CMTM2-/- (n=5) WT (n=50) 36 0* 0* 0* 72.0 4*
M, male; F, female. Average offspring amount (AOA) was calculated as the total number of offspring divided by the number of 
females that gave birth to offspring. Frequency of copulatory plug (FCP) was calculated as the ratio of the number of plugged 
females to total number of females to which males with the same genotype had access. Frequency of conception (FC) was 
calculated as the ratio of the number of females that gave birth to offspring to total number of females. *P < 0.001.
Figure 5. Testis histology in CMTM2 mutant mice. A. Histological staining of 
testis with hematoxylin and eosin (HE). Nearly complete germ cell loss is ap-
parent in CMTM2-/- testis, whereas CMTM2+/+, CMTM2+/- testes look normal. 
B. Spermatogonial depletion CMTM2-/- mice, CMTM2+/- mice look normal in 
comparison with CMTM2+/+ animals, whereas a progressive germ cell loss is 
also could be observed. 
CMTM2+/+ mice was lost in 
CMTM2-/- mice (Figure 5). 
Contrary to the wild-type mice, 
the lumina of the seminifer-
ous tubules in CMTM2-/- mice 
have a typically irregular con-
tour or the lumen may even 
be obliterated. Furthermore, 
segments of CMTM2-/- mice 
seminiferous tubules have 
very few spermatogenic cells, 
only some round spermatids 
could be observed (Table 3). 
As their seminal fluid is devoid 
of mature spermatazoa, this 
indicated a complete block of 
spermatogenesis. The semini- 
ferous epithelium of CMTM2+/- 
mice has reduced numbers 
of spermatogonia, resulting in 
reduced sperm production. 
There were no significant dif-
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The previous study showed that CMTM2 was 
localized to the endoplasmic reticulum near the 
Golgi apparatus [9]. As is known, during the 
post-meiotic germ cell development, sperma-
tids undergo dramatic morphological transfor-
mations and structural modifications of the 
Golgi apparatus, centriolar-axonemal complex, 
mitochondria and endoplasmic reticulum [12]. 
In addition, CMTM2 contains MARVEL, a novel 
domain with a four transmembrane helix archi-
tecture that has been identified in proteins of 
the myelin and lymphocyte (MAL), physins, 
gyrins and occluding families. Their function 
could be related to cholesterol-rich membrane 
apposition events in a variety of cellular pro-
cesses, such as biogenesis of vesicular trans-
port carriers [13]. 
Fertility tests showed no significant differences 
in the ability of male mice of any genotype to 
plug wild type females. However, the CMTM2-/- 
mice produced no sperm, while the CMTM2+/- 
mice exhibited significantly reduced sperm 
count and motility which already affected fertil-
ity rate. In human, male infertility patients fre-
quently have low sperm motility, and it is well 
known that sperm motility is a critical parame-
ter that defines normal semen [14]. Men with 
impaired sperm motility have reduced fertiliza-
tion possibility which may result in infertility 
[15]. Human beings with gene deficiency would 
be more vulnerable to pathological factors and 
lifestyles, including other genetic disorders, 
genital tract infections, environmental contami-
nation and cigarette smoking [16]. It is ackn- 
owledged that accumulation of these mild 
defects could cause male infertility. In addition 
to multiple pathological factors, such as radia-
tion and reactive oxygen species, genetic disor-
ders can play a key role in sperm damage [17]. 
In contrast to females, male CMTM2-/- mice are 
sterile due to a complete block of spermatogen-
esis. CMTM2 deficiency is not lethal for devel-
opment of spermatozoa within the epithelium 
of the seminiferous tubules in mice. The rare 
spermatozoa in CMTM2-/- mice are morphologi-
cally incomplete, and the spermatogenesis 
proceeds normally up until the transition from 
round to elongating spermatids. In wild-type 
mice, this transition is preceded by strong 
expression of CMTM2 in the nuclei of round 
spermatids. Simultaneously, CASA revealed dif-
ferences in sperm motility between CMTM2-
deficient mice and wild type mice. Given that 
CMTM2 is a novel protein that has been cloned 
recently, its biological function remains unclear 
[18, 19]. It is proposed that the arrest in sper-
miogenesis at the transition from round to elon-
gating spermatids may be explained by the 
absence of expression of specific haploid 
genes, though we did not examine the expres-
sion of the critical activator protein CREM [20, 
21] as well as that of many other well-charac-
terized testis-specific genes. The expression of 
these genes normally begins in step 5-7 round 
spermatids, and their mRNAs persist in elon-
gating spermatids [22, 23]. The onset of their 
transcription, therefore, coincides with a peak 
of CMTM2 expression, and although we cannot 
exclude an indirect effect, this suggests that 
their expression may be directly controlled by 
CMTM2. These genes have not yet been fully 
characterized, and their precise functions are 
not known. Nevertheless, in the absence of 
their expression in CMTM2 null mice spermio-
genesis is arrested, suggesting that they are 
essential for the maturation of elongating 
spermatids.
There are several limitations for this article: 
first of all, as this is only an early phase obser-
vation study on CMTM2 in mice, we did not con-
duct the time-based dynamic observational 
study on CMTM2 null mice; secondly, we did 
not conduct the apoptosis study to elucidate 
whether excessive apoptosis is involved in the 
reduced spermatogenesis, and we also did not 
conduct many other studies, like electron 
microscopy, in situ hybridization, immmunofluo-
Table 3. The number of cells in the seminiferous epithelium of seminiferous tubules in CMTM2 mu-
tant mice
Genotype SG PSC SSC Spermatids Sperms Sertoli cells
CMTM2+/+ (n=5) 39.11±2.98 67.92±1.03 2.96±0.73 139.22±7.81 40.84±5.92 9.21±1.29
CMTM2+/- (n=5) 37.73±4.55 63.34±6.01 2.29±0.74 128.18±8.17 29.28±3.44 9.45±1.78
CMTM2-/- (n=5) 14.22±5.01* 20.18±8.82* 0.00±0.00* 30.84±13.89* 0.00±0.00* 9.01±1.54
Values are mean ± SEM. SG-spermatogonia, PSC-primary spermatocytes, SSC-secondary spermatocytes. *P < 0.001.
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rescence microscopy. We are going to provide 
these above mentioned study results in future 
study, and will try to elucidate the mechanisms 
of CMTM2 involvement in spermatogenesis. 
However, the molecular and cellular mecha-
nism of CMTM2 remains elusive and needs fur-
ther investigation. In conclusion, we success-
fully generated mouse model with CMTM2 
deficiency, and confirmed the reproductive phe-
notype, fertility status and testis changes of 
the CMTM2 null mice. Furthermore, we believed 
the CMTM2 is involved in the post-meiotic 
phase spermatogenesis and apoptosis. Here 
we report that CMTM2 is one of the genes likely 
involved in male infertility, and further study is 
required. 
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